Ldn Tsh Elisa
Lab Reagents
Human IgG antibody Laboratories manufactures the ldn tsh elisa reagents distributed by Genprice. The Ldn Tsh Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tsh elisa. Other Ldn products are available in stock. Specificity: Ldn Category: Tsh Group: Elisa
Rat Thyroid Stimulating Hormone (TSH) ELISA Kit |
|||
| RDR-TSH-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 640.8 |
Rat Thyroid Stimulating Hormone (TSH) ELISA Kit |
|||
| RDR-TSH-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 890.4 |
LDN 57444 |
|||
| A4003-10 | ApexBio | 10 mg | EUR 212.4 |
|
Description: LDN 57444 is a reversible competitive inhibitor of ubiquitin C-terminal hydrolase L1 (Uch-L1) with IC50 value of 0.88?M [1].Besides Uch-L1, LDN 57444 also inhibits Uch-L3 with a higher IC50 value of 25?M. |
|||
LDN 57444 |
|||
| A4003-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 205.2 |
|
Description: LDN 57444 is a reversible competitive inhibitor of ubiquitin C-terminal hydrolase L1 (Uch-L1) with IC50 value of 0.88?M [1].Besides Uch-L1, LDN 57444 also inhibits Uch-L3 with a higher IC50 value of 25?M. |
|||
LDN 57444 |
|||
| A4003-50 | ApexBio | 50 mg | EUR 393.6 |
|
Description: LDN 57444 is a reversible competitive inhibitor of ubiquitin C-terminal hydrolase L1 (Uch-L1) with IC50 value of 0.88?M [1].Besides Uch-L1, LDN 57444 also inhibits Uch-L3 with a higher IC50 value of 25?M. |
|||
LDN-211904 |
|||
| C4541-1 | ApexBio | 1 mg | EUR 141.6 |
|
Description: IC50: 79 nM for EphB3 LDN-211904 is an inhibitor of erythropoietin-producing hepatocellular carcinoma (Eph) receptors. |
|||
LDN-211904 |
|||
| C4541-10 | ApexBio | 10 mg | EUR 510 |
|
Description: IC50: 79 nM for EphB3 LDN-211904 is an inhibitor of erythropoietin-producing hepatocellular carcinoma (Eph) receptors. |
|||
LDN-211904 |
|||
| C4541-5 | ApexBio | 5 mg | EUR 325.2 |
|
Description: IC50: 79 nM for EphB3 LDN-211904 is an inhibitor of erythropoietin-producing hepatocellular carcinoma (Eph) receptors. |
|||
LDN-57444 |
|||
| 2016-25 | Biovision | EUR 444 | |
LDN-57444 |
|||
| 2016-5 | Biovision | EUR 157.2 | |
LDN-57444 |
|||
| 20-abx076622 | Abbexa |
|
|
LDN-193189 |
|||
| A8324-10 | ApexBio | 10 mg | EUR 282 |
|
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
|||
LDN-193189 |
|||
| A8324-5 | ApexBio | 5 mg | EUR 177.6 |
|
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
|||
LDN-193189 |
|||
| A8324-50 | ApexBio | 50 mg | EUR 895.2 |
|
Description: LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor. It inhibits activin receptor-like kinase-2 (ALK2) and ALK3 with IC50 values of 5 nM and 30 nM, respectively [1]. |
|||
Ldn-57444 |
|||
| abx188748-1g | Abbexa | 1 g | EUR 1680 |
LDN-212854 |
|||
| B2641-1 | Biovision | 1 mg | EUR 150 |
LDN-212854 |
|||
| B2641-5 | Biovision | 5 mg | EUR 393.6 |